Department of Clinical Pharmaceutical Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan.
Brain Res. 2010 Sep 24;1353:152-8. doi: 10.1016/j.brainres.2010.07.037. Epub 2010 Jul 29.
Nicotine has ameliorating effects on sensorimotor gating deficits in schizophrenia. We have shown that nicotine ameliorated disruption of prepulse inhibition (PPI) via the alpha(7) nicotinic acetylcholine receptor (nAChR) in Wistar rats. The 5-HT(3) receptor antagonist tropisetron was recently found to be an alpha(7) nAChR partial agonist. We initially investigated the effects of tropisetron on disruption of PPI induced by phencyclidine (PCP) (2mg/kg) or apomorphine (1mg/kg). Tropisetron had no effect on the disruption of PPI induced by PCP, but ameliorated the disruption by apomorphine. The ameliorating effect of tropisetron was antagonized by methyllycaconitine (2 or 5mg/kg), a partially selective alpha(7) nAChR antagonist. Next, to find the action site of tropisetron, we examined c-Fos protein expression in the nucleus accumbens (NAc), dorsolateral striatum (DLst) and ventral tegmental area (VTA). Tropisetron alone did not change the number of c-Fos-positive cells, whereas apomorphine increased the number of positive cells in the NAc and DLst. Tropisetron administration followed by apomorphine administration decreased the number of positive cells in the VTA compared with the apomorphine-alone group. These results suggest that tropisetron has an ameliorating effect on the sensorimotor gating deficits via the alpha(7) nAChR, and that one possible site of its action is the VTA.
尼古丁可改善精神分裂症患者的感觉运动门控缺陷。我们曾表明,尼古丁可通过烟碱型乙酰胆碱受体(nAChR)α7 亚型改善 Wistar 大鼠的预脉冲抑制(PPI)破坏。5-羟色胺(5-HT)3 受体拮抗剂曲匹司特最近被发现为 nAChRα7 部分激动剂。我们最初研究了曲匹司特对苯环利定(PCP,2mg/kg)或阿扑吗啡(1mg/kg)诱导的 PPI 破坏的影响。曲匹司特对 PCP 诱导的 PPI 破坏无影响,但可改善阿扑吗啡引起的 PPI 破坏。α7 nAChR 部分拮抗剂甲基牛扁亭碱(2 或 5mg/kg)拮抗了曲匹司特的改善作用。接下来,为了确定曲匹司特的作用部位,我们检测了伏隔核(NAc)、背外侧纹状体(DLst)和腹侧被盖区(VTA)中的 c-Fos 蛋白表达。曲匹司特本身不会改变 c-Fos 阳性细胞的数量,而阿扑吗啡会增加 NAc 和 DLst 中的阳性细胞数量。与单独使用阿扑吗啡组相比,曲匹司特给药后再给予阿扑吗啡可减少 VTA 中的阳性细胞数量。这些结果表明,曲匹司特通过 nAChRα7 对感觉运动门控缺陷具有改善作用,其作用部位之一可能是 VTA。